Johns Hopkins study highlights promise of IV mistletoe extract for cancer therapy mendocinobeacon.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mendocinobeacon.com Daily Mail and Mail on Sunday newspapers.
A phase 1 drug trial using mistletoe extract to treat cancer patients was recently completed by the Johns Hopkins School of Medicine and it found that the treatment, commonly used in Europe, is safe. and appeared to improve the quality of life of those receiving treatment for cancer.
10-Year Study Confirms High Success of HER2+ Breast Cancer Therapy miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Eight of nine patients with major pathological response (MPR) were alive and disease-free at five years, while six of 11 without MPR experienced relapse